Antibiotic Prophylaxis and Treatment of Surgical Abdominal Sepsis

References

• Centers for Disease Control and Prevention, National Center for Health Statistics. Mortality patterns—United States. 1990. Monthly Vital Stat Rep 1993; 41: 45.
   Google Scholar
• Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Center for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Contr 1999; 27: 97–132.
   PubMed Web of Science ®Google Scholar
• Mora RJF. Malnutrition: organic and functional conse-quences. World J Surg 1999; 23: 530–35.
   PubMed Web of Science ®Google Scholar
• Garner JS, Jarvis WR, Emory TG, et al. CDC defini-tions for nosocomial infections, 1988. Ann Infect Contr 1988; 16: 128–40.
   PubMed Web of Science ®Google Scholar
• Geiss HK. Periperative antibiotikaprophylaxe aus mikro-biologischer sicht. Langernbecks Arch Chir Suppl Kongressbd 1997; 114: 1019–21.
   PubMedGoogle Scholar
• Klaue HJ, Bauer E. Retroperitoneal phlegmon after transanal endoscopic microsurgical excision of rectal adeno-ma. Chirurg 1997; 68: 84–6.
   PubMed Web of Science ®Google Scholar
• Molloy RG, Kingsmore D. Life threatening pelvic sepsis after stapled haemorrhoidectomy. Lancet 2000; 355: 768–9.
   PubMed Web of Science ®Google Scholar
• Colizza S, Rossi S. Razionale della profilassi antibiotica in chirurgia. Arch Atti Soc It Chir 2000; 1: 249–98.
   Google Scholar
• Schilling J, Michalopoulos A, Geroulanos S. Antibiotic prophylaxis in gastroduodenal surgery. Hepato-Gastro-enterology 1997; 44: 116–20.
   PubMed Web of Science ®Google Scholar
• Montorsi W, Germiniani R. Pefloxacina vs ceftriaxone nella profilassi antibiotica in monodose in chirurgia generale pulita-contaminata. Gruppo di studio pefloxacina. Minerva Chir 1997; 52: 539–48.
   Google Scholar
• Dormann AJ, Wigginhaus B, Risius H, et al. A single dose of cefgriaxone administered 30 minutes before percuta-neous endoscopic gastrostomy significantly reduced local and systemic infective complications. Am J Gastroenterol 1999; 94: 3220–4.
   PubMed Web of Science ®Google Scholar
• Dormann AJ, Wigginhaus B, Risius H, et al. Antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG). Results from a prospective randomized multicenter trial. Zeitschrift fur Gastroenterol 2000; 38: 229–34.
   Google Scholar
• Sturgis TM, Yancy W, Cole JC, et al. Antibiotic pro-phylaxis in percutaneous endoscopic gastrostomy. Am J. Gastroenterol 1996; 91: 2301–4.
   PubMed Web of Science ®Google Scholar
• Garcia N, Kapur S, McClane J, Davis JM. Surgical infections and prophylactic antibiotics: 341 consecutive cases of gallbladder surgery in the era of laparoscopic surgery. Laparoendoscopic Adv Surg Tech 1997; 7: 157–62.
   PubMed Web of Science ®Google Scholar
• Jewesson PJ, Stiver G, Wai A, et al. Double-blind com-parison of cefazolin and ceftizoxime for prophylaxis against infections following elective biliary tract surgery. Antimicrob Agents Chemother 1996; 40: 70–4.
   PubMed Web of Science ®Google Scholar
• IIlig KA, Schmidt E, Cavavaugh J, et al. Are prophylac-tic antibiotics required for elective laparoscopic cholecystecto-my? J Am Coll Surg 1997; 184: 353–6.
   PubMed Web of Science ®Google Scholar
• Dobay KJ, Freier DT, Albear P. The absent role of prophylactic antibiotics in low-risk patients undergoing laparo-scopic cholecystectomy. Am Surg 1999; 65: 226–8.
   PubMed Web of Science ®Google Scholar
• Hell K. Antibiotika-prophilaxe bei cholezystektomie-notwending und kostenspared? Zentralbl Chir 1998; 123 (suppl): 37-41.
   Google Scholar
• Tocchi A, Lepre L, Costa G, et al. The need for antibi-otic prophylaxis in elective laparoscopic cholecystectomy: a prospective randomized study. Arch Surg 2000; 135: 67–70.
   PubMedGoogle Scholar
• Periti P. Introduction: cephalosporin generations. J Chemother 1996; 8 (suppl): 3-6.
   Google Scholar
• Yellin AE, Berne TV, Appleman MD, et al. A random-ized study of cefepime vs the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis. Surg Gynec Obst 1993; 177 (suppl): 23-9.
   Google Scholar
• Thompson JE, Bennion RS, Roettger R, et al. Cefepime for infections of the biliary tract. Surg Gynecol Obst 1993; 177 (suppl): 30-4.
   Google Scholar
• Okamoto MP, Gill MA, Nakahiro RK, et al. Cefepime pharmacokinetics in patients with acute cholecystitis undergo-ing cholecystectomy. Clin Pharm 1993; 12: 134–7.
   PubMedGoogle Scholar
• El Mufti MB, Rakas FS, Glessa A. Ceftriaxone vs clavu-lanate-potentiated amoxicillin for prophylaxis against post-operative sepsis in biliary surgery: a prospective randomized study in 200 patients. Curr Med Res Opin 1989; 11: 354–61.
   PubMed Web of Science ®Google Scholar
• Sainio V, Kemppainen E, Puolakkainen P, et al. Early antibiotic treatment in acute necrotizing pancreatitis. Lancet 1995; 346: 663–7.
   PubMed Web of Science ®Google Scholar
• Oldach D. Antibiotic prophylaxis for necrotizing pan-creatitis. Lancet 1995; 346: 652.
   PubMed Web of Science ®Google Scholar
• Pederzoli P, Bassi C, Vesentini S, Campedelli A. A ran-domized multicenter clinical trial of antibiotic prophylaxis of septic complications in acute necrotizing pancreatitis with imipenem. Surg Gynecol Obst 1993; 176: 480–3.
   PubMedGoogle Scholar
• Bassi C, Pederzoli P, Vesentini S, et al. Behaviour of antibiotics during human necrotizing pancreatitis. Antimicrob Agents Chemother 1994; 38: 830–6.
   PubMed Web of Science ®Google Scholar
• Shliapnikov SA, Rybkin AK. The role of cefepime, a 4th generation cephalosporin, in treating patients with surgical sepsis. Antibiot Khimioter 1999; 44: 34–6.
   PubMedGoogle Scholar
• Suchler M, Malfertheiner P, Friess H, et al. Human pancreatic tissue concentration of bactericidal antibiotics. Gastroenterology 1992; 103: 1902–8.
   PubMed Web of Science ®Google Scholar
• Martin C, Cottin A, Francois-Godfroy N, et al. Concentrations of prophylactic ceftriaxone in abdominal tis-sues during pancreatic surgery. J Antimicrob Chemother 1997; 40: 445–8.
   PubMed Web of Science ®Google Scholar
• Jang L, Peng Q, Yao Y. Penetration of ciprofloxacin and cefoperazone into human pancreas. Hua Xi Yi Ke Xue Xue Bao 1997; 28: 365–8.
   PubMedGoogle Scholar
• Ohge H, Takesue Y, Yokoyama T, et al. An additional dose of cefazolin for intraoperative prophylaxis. Surg Today 1999; 29: 1233–6.
   PubMed Web of Science ®Google Scholar
• Styrt B, Gorbach S. Prophylactic antibiotics for bowel surgery. In: Remington JS, Swartz MN (eds), Current clinical topics in infectious disease. New York: McGraw-Hill Book Co., 1982.
   Google Scholar
• Nyam DCNK, Yeo N, Cheong M, Goh HS. Antibiotic prophylaxis in colorectal surgery: a randomized double-blind, controlled trial of amoxicillin-clavulanic acid vs ceftriaxone and metronidazole. Asian J Surg 1995; 18: 227–30.
   Google Scholar
• Quendt J, Blank I, Seidel W. Peritoneal and subcuta-neous administration of cefazolin as perioperative antibiotic prophylaxis in colorectal operations. Prospective randomized comparative study of 200 patients. Langenbecks Arch Chir 1996; 381: 18–22.
   PubMedGoogle Scholar
• ToneIli F, Dentico P, Novelli A, Periti P. Short-term antibiotic prophylaxis with cefodizime in colorectal surgery: a comparaative multi-center study. It J Coloproctol 1997; 4: 203–7.
   Google Scholar
• Milmson JW, Smith DL, Corman ML, et al. Double-blind comparison of single-dose alatrofloxacin and cefotetan as prophylaxis of infection following elective colorectal surgery. Am J Surg 1998; 176: 46–52.
   PubMed Web of Science ®Google Scholar
• Luke DR. Alatrofloxacin versus cefotetan in prophylaxis of colorectal surgery. Drugs 1998; 58 (suppl 2): 286-7.
   Google Scholar
• Zanella E, Rulli F. A multicenter randomized trial of prophylaxis with intravenous cefepine + metronidazole or cef-triaxone + metronidazole in colorectal surgery. J Chemother 2000; 12: 120–7.
   Google Scholar
• Song F, Glenny AM. Antimicrobial prophylaxis in col-orectal surgery: a systematic review of randomized controlled trials. Health Technol Assoc 1998; 2: 1–110.
   Google Scholar
• Kumarakrishnan S, Srinivasan K, Sahai A, et al. A trial of various regimes of antibiotics in acute appendicitis. Trop Gastroenterol 1997; 1884: 177–9.
   Google Scholar
• Shubing W, Litian Z. Preventing infection of the inci-sion after appendectomy by using metronidazole preoperative-ly to infiltrate tissues at the incision. Am J Surg 1997; 174: 422–4.
   PubMed Web of Science ®Google Scholar
• Berne TV, Yellin AE, Appleman MD, et al. A clinical comparison of cefepime and metronidazole vs gentamycin and clindamycin in the antibiotic management of surgically treated advanced appendicitis. Surg Gynecol Obst 1993; 177: 18–22.
   PubMedGoogle Scholar
• Bohnem JMA. Antibiotic therapy for abdominal infec-tion. World J Surg 1998; 22: 152–7.
   PubMed Web of Science ®Google Scholar
• Bohen J. Principles of perioperative antibacterial pro-phylaxis. Management of surgical site infection. Dis Manag Health Outcomes 1999; 6: 73–81.
   Google Scholar
• Bohnem JMA, Solomkin JS, Page CP. Guidelines for clinical care: antiinfective agents for intraabdominal infection. Arch Surg 1992; 127: 83–90.
   PubMedGoogle Scholar
• Montravers P, Lepers S, Popesco D. Prise en charge post-operatoire. Reanimation des sepsis intra-abdominaux apres intervention chirurgicale. Presse Med 1999; 28: 198–202.
   Google Scholar
• Lorenz D. Treatment of an infected focus, considera-tions and facts on duration of antibiotic therapy. Langenbecks Arch Chir Suppl Kongressbd 1998; 115: 612–4.
   PubMedGoogle Scholar
• Geroulanos SJ and the Meropenem Study Group. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. J Antimicrob Chemother 1995; 36 (Suppl A): 191-205.
   Google Scholar
• Norrby SR, Faulkner KL, Newell PA. Differentiating meropenem and imipenem-cilastatin. Infect Dis Clin Pract 1997; 6 (5): 291–303.
   Web of Science ®Google Scholar
• ToneIli F. Meropenem (Merrem) vs imipenem/cilastati-na nel trattamento ospedaliero delle infezioni intra-addominali. Minerva Chir 1997; 52: 317–26.
   PubMedGoogle Scholar
• Basoli A, Zarba Meli E, Mazzocchi P, Speranza V. Imipenem-cilastatin vs meropenem in patients with intraab-dominal infections: results of a prospective randomized multi-centre trial. Scand J Infect Dis 1997; 29: 503–8.
   PubMed Web of Science ®Google Scholar
• Brismar B, Nord CE. Monobactams and carbapenems for treatment of intraabdominal infections. Infection 1999; 27: 136–47.
   PubMedGoogle Scholar
• Zanetti G, Harbarth SJ, Glauser M, et al. Meropenem is as effective as imipenem/cilastatin for the treatment of moderately severe intra-abdominal infections. Int J Antimicrob Agents 1999; 11: 107–13.
   PubMed Web of Science ®Google Scholar
• Huizinga WKJ, Warren BL, Baker LW, et al. Antibiotic monotherapy with meropenem in the surgical management of intra-abdominal infections. J Antimicrob Chemother 1995; 36: 179–89.
   PubMed Web of Science ®Google Scholar
• Wilson SE. Carbapenems: monotherapy in intra-abdom-inal sepsis. Scand J Infect Dis 1995; 96 (Suppl): 28-33.
   Google Scholar
• Solomkin JS, Reinhart HH, Echols RM. Results of a randomized trial comparing sequential i.v./oral treatment with ciprofloxacin plus metronidazole to imipenem-cilastatin for intraabdominal infections. Ann Surg 1996; 23: 303–15.
   Google Scholar
• Buie PS, Vogel SB, Dellinfer EP, Baumgartner TF. A randomized, double-blind clinical trial comparing cefepime plus metronidazole with imipenem-cilastatin in the treatment of complicated intra-abdominal infections. Arch Surg 1997; 132: 1294–302.
   PubMedGoogle Scholar
• Perry CM, Markham A. Piperacillin/tazobactam: an update review of its use in the treatment of bacterial infec-tions. Drugs 1999; 57 (5): 805–43.
   PubMed Web of Science ®Google Scholar
• Moellering RC, Linden PK, Reinhardt J, et al. The effi-cacy and safety of quinopristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother 1999; 44: 251–61.
   Google Scholar
• Pecherê JC. Current and future management of infec-tions due to methicillin-resistant staphylococci infections: the role of quinopristin/dalfopristin. J Antimicrob Chemother 1999; 44 (topic a): 11-8.
   Google Scholar
• Ho HS, Frey CF. The role of antibiotic prophylaxis in severe acute pancreatitis. Arch Surg 1997; 132: 487–92.
   PubMedGoogle Scholar
• Wittmann DH. Operative and non-operative therapy of intraabdominal infections. Infection 1998; 26: 335–41.
   PubMed Web of Science ®Google Scholar
• Giamarellou H. Fourth generation cephalosporins in the antimicrobial chemotherapy of surgical infections. J Chemother 1999; 11: 486–93.
   PubMed Web of Science ®Google Scholar
• Koperna T, Schulz F. Relaparotomy in peritonitis: prog-nosis and treatment of patients with persisting intraabdominal infection. World J Surg 2000; 24: 32–7.
   PubMed Web of Science ®Google Scholar
• Tons C, Schachtrupp A, Rau M, et al. Abdominal com-partment syndrome: prevention and treatment. Chirurg 2000; 71: 918–26.
   PubMed Web of Science ®Google Scholar
• Echenique AM, Sleeman D, Yrizarry J, et al. Percutaneous catheter-directed debridement of infected pan-creatic necrosis: results in 20 patients. J Vasc Intervent Radiol 1998; 9: 565–71.
   Google Scholar
• Tabrizi AR, Zehnbauer BA, Freeman BD, Buchman TG. Genetic markers in sepsis. J Am Coll Surg 2001; 192: 106–17.
   PubMed Web of Science ®Google Scholar